Article Details

AstraZeneca inks $760 mln deal with Swiss firm Neurimmune for antibody drug | Reuters

Retrieved on: 2022-03-01 07:46:45

Tags for this article:

Click the tags to see associated articles and topics

AstraZeneca inks $760 mln deal with Swiss firm Neurimmune for antibody drug | Reuters. View article details on HISWAI: https://www.reuters.com/world/uk/astrazeneca-inks-760-mln-deal-with-swiss-firm-neurimmune-antibody-drug-2022-03-01/

Excerpt

AstraZeneca Plc said on Tuesday it had agreed with Swiss biotechnology firm Neurimmune to develop an antibody-based therapy for a rare, ...

Article found on: www.reuters.com

View Original Article

This article is found inside other Hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up